Documentation
Corporate
2011 Sustainable Development and Activity report
Corporate
Roquette Group Communication Kit
Corporate
2010 Sustainable Development Report
Pharma and Personnal Care
FORMULATING WITH ROQUETTE EXCIPIENTS / Product guide – 21 pages
For each pharma applications, the guide allows you to choose different products by functionality, and by conformity to the main pharmacopeias.
Corporate
Publication of the second sustainable development report for Roquette
Pharma and Personnal Care
KLEPTOSE® CRYSMEB exp – Methyl Beta-cyclodextrin from Roquette - 14 pages
CRYSMEB is a unique low methylated derivative of betacyclodextrin. The degree of methylation is controlled in such a manner that the derivative has an advantageous profile of solubilising power and biological tolerance.
CRYSMEB could be an alternative solution for cyclodextrin-drug formulations.
Pharma and Personnal Care
LYCASIN® 80/55 sugarless excipient for medicinal preparations – 22 pages
A technical brochure incorporating a general introduction to this type of excipient, with detailed information on the physical, chemical and microbiological characteristics of LYCASIN® 80/55. Its biological properties and examples of pharmaceutical applications are also included.
